OMDANasdaqServices-Health ServicesFiscal year ends December 31
Omada Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$18.06+0.43 (+2.44%)
Close on Oct 19, 2026
- Market cap
- $1.15B
- P/E (TTM)
- –
- Dividend yield
- –
Omada Health, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Services | $80.69M | $69.59M | $71.65M | $62.94M | $56.96M | $49.50M | $45.44M | $42.10M | $38.35M | 91.9% | +41.7% |
| Hardware | $7.14M | $8.45M | $4.20M | $5.09M | $4.41M | $5.47M | $2.54M | $3.42M | $2.86M | 8.1% | +61.9% |
By region
From the segment and revenue-disaggregation notes of Omada Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.